Recent news on Levalbuterol Hydrochloride

Sepracor Announces First Quarter 2006 Results  Apr 25, 2006
ANDA) including a Paragraph IV certification, which was submitted to the FDA by Dey, LP, for a generic version of levalbuterol hydrochloride inhalation solution ... - Genetic Engineering News

Sepracor Announces First Quarter 2006 Results  Apr 25, 2006
ANDA) including a ParagraphIV certification, which was submitted to the FDA by Dey, LP, for ageneric version of levalbuterol hydrochloride inhalation solution ... - Finanzen.net



Sepracor Receives Notice of Second Abbreviated New Drug ...  Jan 12, 2006
FDA) has received an abbreviated new drug application (ANDA) from Dey, LP for a generic version of levalbuterol hydrochloride inhalation solution. ... - Business Wire

Sepracor Announces Fourth Quarter and Full Year 2005 Results ...  Jan 31, 2006
...that the FDA received an abbreviated new drug application (ANDA) from Breath Limited for a generic version of levalbuterol hydrochloride inhalation solution. ... - Genetic Engineering News

Sepracor Receives Notice of Second Abbreviated New Drug ...  Jan 12, 2006
Administration (FDA) hasreceived an abbreviated new drug application (ANDA) from Dey, LP fora generic version of levalbuterol hydrochloride inhalation solution ... - Finanzen.net

Sepracor to defend Xopenx patents  Jan 12, 2006
Merck KGaA -- had filed a generic drug application with the Food and Drug Administration for a version of inhalable levalbuterol hydrochloride, the active ... - BusinessWeek

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional